Get the Latest Roundup Lawsuit Updates

Settlement Fairness Hearing
On September 14, 2026, Judge Boyer in the 22nd Judicial Circuit Court for the City of St. Louis, Missouri held a fairness hearing to consider approval of the proposed $7.25 billion class settlement program proposed by Bayer/Monsanto. The settlement program is currently pending final court approval following the hearing. Initial claim registration will begin following the court’s approval, with claims becoming payable once the approval order becomes final and non-appealable. However, the program will make “Exigency Awards” available for claimants facing a terminal illness or imminent loss of housing following final court approval, which can be paid while an appeal is filed and pending.

U.S. Supreme Court Rules for Monsanto
In Monsanto Co. v. Durnell, the Supreme Court ruled in favor of Bayer/Monsanto, holding that the Federal Insecticide, Fungicide, and Rodenticide Act (“FIFRA”) preempts state-law failure-to-warn claims that would require a cancer warning beyond what the EPA has required on Roundup's label. The ruling does not preempt other causes of action, such as design defect, negligence, and/or non-label-based failure to warn claims, and Roundup lawsuits can proceed on these additional claims. This ruling does not end the Roundup lawsuits.

$7.25 Billion Class Settlement Announced
Bayer/Monsanto announced a proposed nationwide class settlement to resolve current and future Roundup non-Hodgkin lymphoma claims. The program received preliminary approval on March 4, 2026, subject to the above referenced fairness hearing on September 14, 2026. Final court approval is required before any claims can be paid. Following final approval, Bayer/Monsanto will be required to fund up to $7.25 billion over the coming years to facilitate the settlement.

Monsanto Settling Cases Quietly
Since Dec. 2024, Monsanto has been avoiding jury verdicts by settling cases confidentially before trial. This signals pressure is mounting.

Legal Wins
We continue pushing cases to trial nationwide. A Missouri appellate court recently upheld a $600M jury verdict against Monsanto in our favor. In Barnes v. Monsanto Co., a jury awarded another plaintiff a $2.065 billion verdict against Monsanto, one of the largest verdicts to date. The parties later settled the case for an undisclosed amount prior to completion of an appeal.

A Philadelphia Common Pleas Court ordered Bayer to pay a staggering $2.25 billion to a man who was diagnosed with non-Hodgkin’s lymphoma after using Roundup weed killer in his yard for two decades. “The jury’s unanimous verdict was a condemnation of 50 years of misconduct by Monsanto and a declaration that its misconduct was in reckless disregard of human safety and a substantial cause of his cancer,” his attorneys said in a statement.

While these types of significant verdicts are outliers, they continue to increase pressure on Bayer/Monsanto to resolve their outstanding cases as quickly as possible.

A Missouri jury ordered Bayer to pay $1.56 billion to three Duncan Stubbs clients who claimed the company’s Roundup weedkiller caused their non-Hodgkin’s lymphoma. The jury found that Bayer’s Monsanto business was liable for claims of negligence, design defects and failing to warn plaintiffs of the potential dangers of using Roundup. Each plaintiff was diagnosed with non-Hodgkin’s lymphoma that they alleged was caused by using Roundup on their family property. This monumental verdict is also great news for you, as it strengthens our firm’s position to negotiate for the best possible compensation for all Duncan Stubbs clients.

Over the span of just 2 weeks, Bayer was dealt half a billion in verdict losses as courts sided with the people in 3 trials. A California jury awarded $332 million in damages after they found a man’s use of Roundup on his lawn for three decades led to his non-Hodgkin’s lymphoma diagnosis. A retired restaurant owner was awarded $175 million in Philadelphia after developing NHL after 20 years of Roundup use. And a St. Louis jury awarded a man who had been in remission from NHL for a decade $1.25 million after ruling Bayer failed to properly warm consumers of the potential risks of its weed killer.